NAPS Global India IPO has received a muted response from investors so far, with the subscription reaching nearly 42 per cent ...

ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs 05.03.2025 / 22:07 CET/CEST The issuer is solely responsible for the content of this ...

Symbiosis Pharmaceutical Services has completed the latest inspection by the U.S. FDA of its facilities in Scotland.

The NAPS Global India IPO launched on March 5, priced at ₹90 per share, with a minimum bid of 1,600 shares. The company, a ...

NAPS Global India's SME IPO opened for bidding, aiming to raise Rs 12 crore with a price band of Rs 90 per share.

The CMO/CDMO market is set to evolve rapidly, driven by innovation, outsourcing trends, and the biopharmaceutical revolution.

The Kia EV4 is poised to make a significant impact on the electric vehicle (EV) market by offering a unique and innovative ...

A global elderly and aging population has significant impacts, not only in terms of individual health risk but in terms of ...

As the trend towards the international dispersion of certain value chain activities produces challenges, discover policies to meet these Tax transparency and international co-operation Enhanced ...

At the 2025 Kia EV Day in Tarragona, Spain, Kia unveiled three new electric vehicles: the EV4, PV5, and Concept EV2. These ...